Zai Lab (ZLAB) Payables (2016 - 2026)
Zai Lab (ZLAB) posted Payables of $340.0 million for Q1 2026, down 1.78% sequentially from $346.1 million in Q4 2025, and up 23.0% YoY from $276.4 million in Q1 2025.
Zai Lab (ZLAB) Payables (2016 - 2026) Analysis & Trends
Zai Lab has reported Payables for 11 years, with the latest figure at $340.0 million in Q1 2026.
- Quarterly Payables rose 23.0% year-over-year to $340.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $340.0 million (up 23.0% YoY) and the FY2025 annual result came in at $346.1 million, up 48.8% from the prior year.
- Payables slipped to $340.0 million in Q1 2026 per ZLAB's latest filing, from $346.1 million in the prior quarter.
- Over five years, Payables peaked at $346.1 million in Q4 2025 and troughed at $55.0 million in Q3 2023.
- A 5-year average of $177.1 million and a median of $136.4 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables slumped 47.71% in 2022, then jumped 324.66% in 2024.
- Over 5 years, Payables stood at $66.0 million in 2022, then soared by 71.27% to $113.0 million in 2023, then jumped by 105.87% to $232.6 million in 2024, then soared by 48.8% to $346.1 million in 2025, then dropped by 1.78% to $340.0 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $340.0 million, $346.1 million, and $302.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 374.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 374.80 Mn |
| Mar 31, 2026 | 339.99 Mn |
| Dec 31, 2025 | 346.14 Mn |
| Sep 30, 2025 | 302.73 Mn |
| Jun 30, 2025 | 281.87 Mn |
| Mar 31, 2025 | 276.42 Mn |
| Dec 31, 2024 | 232.62 Mn |
| Sep 30, 2024 | 233.65 Mn |
| Jun 30, 2024 | 197.64 Mn |
| Mar 31, 2024 | 136.39 Mn |
| Dec 31, 2023 | 112.99 Mn |
| Sep 30, 2023 | 55.02 Mn |
| Jun 30, 2023 | 67.03 Mn |
| Mar 31, 2023 | 66.36 Mn |
| Dec 31, 2022 | 65.97 Mn |
| Sep 30, 2022 | 90.11 Mn |
| Jun 30, 2022 | 108.44 Mn |
| Mar 31, 2022 | 98.16 Mn |
| Dec 31, 2021 | 126.16 Mn |
| Sep 30, 2021 | 51.41 Mn |